{
  "id": 12622818,
  "title": "STAT+: Justice Department targets drugmakers in new directive on combating white-collar fraud",
  "url": "https://urgent.news/2026/10/07/stat-justice-department-targets-drugmakers-in-new-directive-on",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-07T12:10:42.000Z",
  "source": {
    "name": "STAT News",
    "slug": "stat-news",
    "url": "https://www.statnews.com/pharmalot/2026/10/07/trump-administration-adds-pharma-to-list-priorities-combating-white-collar-fraud/"
  },
  "original_language": "en",
  "account": "The U.S. Department of Justice recently released a new directive aimed at combating fraud in the pharmaceutical industry, according to the National Fraud Enforcement Division. This directive explicitly includes the Federal Food, Drug, and Cosmetic Act, signaling a shift in the agency's focus towards drug and device manufacturers. Historically, the agency has primarily pursued health fraud cases involving providers, clinics, home health agencies, and hospices. Kevin Lowell, a former deputy chief in the National Fraud Enforcement Division's health care fraud section, noted that this expansion of the DOJ's jurisdiction is subtle yet significant.",
  "summary": "The Justice Department issued a new directive for combating fraud that noted the agency will pursue violations of a federal law that tightly regulates the pharmaceutical industry.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}